Leukocytosis and the retinoic acid syndrome in patients with acute promyelocytic leukemia treated with arsenic trioxide

Journal of Clinical Oncology

Volumn 18, Issue 13, 2000, Pages 2620-2625

  Camacho, Luis H ^a   Soignet, Steven L ^a   Chanel, Suzanne ^a   Ho, Raymond ^a   Heller, Glenn ^a   Scheinberg, David A ^a   Ellison, Ralph ^a   Warrell Jr , Raymond P ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARSENIC TRIOXIDE;

ACUTE MYELOBLASTIC LEUKEMIA; ARTICLE; CLINICAL ARTICLE; DRUG EFFICACY; DYSPNEA; FEVER; HUMAN; LEUKEMIA REMISSION; LEUKOCYTE COUNT; LEUKOCYTOSIS; LUNG INFILTRATE; MYALGIA; PLEURA EFFUSION; PRIORITY JOURNAL; RETINOIC ACID SYNDROME; SYMPTOMATOLOGY; WEIGHT GAIN;

EID: 0033916673     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2000.18.13.2620     Document Type: Article

References (48)

1. Fenaux P, Chastang C, Chevret S, et al: A randomized comparison of all transretinoic acid (ATRA) followed by chemotherapy and ATRA plus chemotherapy and the role of maintenance therapy in newly diagnosed acute promyelocytic leukemia. Blood 94:1192-1200, 1999
2. Soignet S, Fleischauer A, Polyak T, et al: All-trans retinoic acid significantly increases 5-year survival in acute promyelocytic leukemia: An updated analysis of the New York study. Cancer Chemother Pharmacol 40:S25-S29, 1997 (suppl)
3. Tallman MS, Anderson JW, Schiffer CA, et al: All-trans retinoic acid in acute promyelocytic leukemia. New Engl J Med 337:1021-1028, 1997
4. Avvisati G, Lo Coco F, Diverio D, et al: AIDA (all-trans retinoic acid + idarubicin) in newly diagnosed acute promyelocytic leukemia: A Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto (GIMEMA) pilot study. Blood 88:1390-1398, 1996
5. Kanamaru A, Takemoto Y, Tanimoto M, et al: Alll-trans retinoic acid for the treatment of newly diagnosed acute promyelocytic leukemia. Blood 85:1202-1206, 1995
6. Huang ME, Ye YC, Chen SR, et al: Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia. Blood 72: 567-572, 1988
7. Castaigne S, Chomienne C, Daniel MT, et al: All-trans retinoic acid as a differentiation therapy for acute promyelocytic leukemia: I. Clinical results. Blood 76:1704-1709, 1990
8. Warrell RP Jr, Frankel SR, Miller WH Jr, et al: Differentiation therapy of acute promyelocytic leukemia with tretinoin (all-trans retinoic acid). N Engl J Med 324:1385-1393, 1991
9. Chen ZX, Xue YQ, Zhang RI, et al: A clinical and experimental study on all-trans retinoic acid-treated acute promyelocytic leukemia patients. Blood 78:1413-1419, 1991
10. White KL, Wiley JS, Frost T, et al: All-trans retinoic acid in the treatment of acute promyelocytic leukemia. Aust N Z J Med 22:449-454, 1992
11. Warrell RP, de Thé H, Wang Z-Y, et al: Acute promyelocytic leukemia. New Engl J Med 329:177-189, 1993
12. Hsu HC, Tsai WH, Chen PG, et al: In vitro effect of granulocyte colony-stimulating factor and all-trans retinoic acid on the expression of inflammatory cytokines and adhesion molecules in acute promyelocytic leukemic cells. Eur J Haematol 63:11-18, 1999
13. Dubois C, Schlageter MH, de Gentile A, et al: Modulation of IL-8, IL-1 beta, and G-CSF secretion by all-trans retinoic acid in acute promyelocytic leukemia. Leukemia 8:1750-1757, 1994
14. Grande A, Manfredini R, Tagliafico E, et al: All-trans retinoic acid induces simultaneously granulocytic differentiation and expression of inflammatory cytokines in HL-60 cells. Exp Hematol 23:117-125, 1995
15. Taraboletti G, Borsotti P, Chirivi R, et al: Effect of all-trans-retinoic acid (ATRA) on the adhesive and motility properties of acute promyelocytic leukemia cells. Int J Cancer 70:72-77, 1997
16. Marchetti M, Falanga A, Giovanelli S, et al: All-trans retinoic acid increases the adhesion to endothelium of the acute promyelocytic leukemia cell line NB4. Br J Haematol 93:360-366, 1996
17. Frankel SR, Eardley A, Lauers G, et al: The "retinoic acid syndrome" in acute promyelocytic leukemia. Ann Intern Med 117:292-296, 1992
18. Chamarin N, Smith GB, Green A, et al: Retinoic acid syndrome. Lancet 341:1289-1290, 1993
19. Horikoshi A, Sawada S, Aiso M, et al: A "retinoic acid syndrome" observed in two cases of acute promyelocytic leukemia. Rinsho Ketsueki 34:1044-1049, 1993
20. Castaigne S, Chomienne C, Fenaux P, et al: Hyperleukocytosis during all-trans retinoic acid therapy for acute promyelocytic leukemia. Blood 76:260a, 1990 (suppl. abstr)
21. Hwang WL, Gau JP, Chen MC, et al: Treatment of acute promyelocytic leukemia with all-trans retinoic acid: Successful control of hyperleukocytosis and leukostasis syndrome with leukaphereses and hydroxyurea. Am J Hematol 43:323-324, 1993
22. Dombret H, Sutton L, Duarte M, et al: Combined therapy with all-trans retinoic acid and high-dose chemotherapy in patients with hyperleukocytic acute promyelocytic leukemia and severe visceral hemorrhage. Leukemia 6:1237-1242, 1992
23. Sun HD, Ma L, Hu XC, et al: Treatment of acute promyelocytic leukemia by Ailing-1 therapy with use of syndrome differentiation of traditional Chinese medicine. Chin J Comb Trad Chin Med West Med 12:170-171, 1992
24. Zhang P, Wang SY, Hu XH: Arsenic trioxide treated 72 cases of acute promyelocytic leukemia. Chin J Hematol 17:58-62, 1996
25. 3) in the treatment of acute promyelocytic leukemia (APL): II. Clinical efficacy and pharmacokinetics in patients at relapse. Blood 89:3354-3360, 1997
26. Soignet S, Maslak P, Wang Z-G, et al: Complete remission after treatment of acute promyelocytic leukemia with arsenic trioxide. N Engl J Med 339:1341-1348, 1998
27. Soignet S, Frankel S, Tallman M, et al: U.S. Multicenter trial of arsenic trioxide (AT) in acute promyelocytic leukemia. (APL). Blood 94:698a, 1999 (suppl 1, abstr)
28. 3 induces NB4 cell apoptosis with downregulation of Bcl-2 expression and modulation of PML-RARα/Pml proteins. Blood 88:1052-1061, 1996
29. Shao W, Fanelli M, Ferrara FF, et al: Arsenic trioxide as an inducer of apoptosis and loss of PML-RARα protein in acute promyelocytic leukemia cells. J Natl Cancer Inst 90:124-133, 1998
30. Miller WH Jr, Kakizuka A, Frankel SR, et al: Reverse transcription polymerase chain reaction for the rearranged retinoic acid receptor α locus clarifies diagnosis and detects minimal residual disease in acute promyelocytic leukemia. Proc Natl Acad Sci U S A 89:2694-2698, 1992
31. Warrell RP Jr: Fatal all-trans retinoic acid pneumonitis. Ann Intern Med 118:473, 1993 (letter)
32. Wiley JS, Firkin FC: Reduction of pulmonary toxicity by prednisolone prophylaxis during all-trans retinoic acid treatment of acute promyelocytic leukemia. Leukemia 9:774-778, 1995
33. Vadhat L, Eardley A, Maslak P, et al: Early mortality and the "retinoic acid syndrome" in acute promyelocytic leukemia: Impact of leukocytosis, low-dose chemotherapy, PML/RAR-α isoform, and CD13 expression in patients treated with all-trans retinoic acid. Blood 84:3843-3849, 1994
34. De Botton S, Dombret H, Sanz M, et al: Incidence, clinical features, and outcome of all-trans retinoic acid syndrome in 413 cases of newly diagnosed acute promyelocytic leukemia. Blood 92:2712-2718, 1998
35. Gianni M, Norio P, Terao M, et al: The effect of dexamethasone on proinflammatory cytokine expression, cell growth and maturation during granulocytic differentiation of acute promyelocytic leukemia cells. Eur Cytokine Netw 6:157-165, 1995
36. de Ridder MC, van der Plas AJ, Erpenlinck-Verschueren CA, et al: Dexamethasone does not counteract the response of acute promyelocytic leukaemia cells to all-trans retinoic acid. Br J Haematol 106:107-110, 1999
37. Frankel SR, Eardley A, Heller G, et al: All-trans retinoic acid for acute promyelocytic leukemia: Results of the New York study. Ann Intern Med 120:278-286, 1994
38. Matikainen S, Tapiovaara H, Vaheri A, et al: Activation of interleukin-1 beta gene expression during retinoic acid-induced granulocytic differentiation of promyelocytic leukemia cells. Cell Growth Differ 5:975-982, 1994
39. Tkatch LS, Rubin KA, Ziegler SF, et al: Modulation of human G-CSF receptor mRNA and protein in normal and leukemic myeloid cells by G-CSF and retinoic acid. J Leukoc Biol 57:964-971, 1995
40. de Gentile A, Toubert M-E, Dubois C, et al: Induction of high-affinity GM-CSF receptors during all-trans retinoic acid treatment of acute promyelocytic leukemia. Leukemia 8:1758-1762, 1994
41. Agura ED, Howard M, Collins SJ: Identification and sequence analysis of the promoter for the leukocyte integrin β-subunit (CD18): A retinoic acid-inducible gene. Blood 79:602-609, 1992
42. Di Noto R, Schiavone EM, Ferrara F, et al: Expression and ATRA-driven modulation of adhesion molecules in acute promyelocytic leukemia. Leukemia 8:S71-S76, 1994 (suppl 2)
43. Di Noto R, Schiavone EM, Ferrara F, et al: All-trans-retinoic acid promotes a differential regulation of adhesion molecules on acute myeloid leukaemia blast cells. Br J Haematol 88:247-255, 1994
44. Adams DH, Shaw S: Leukocyte-endothelial interactions and regulation of leukocyte migration. Lancet 343:831-836, 1994
45. Huber AR, Kundel SL, Todd RF, et al: Regulation of transendothelial neutrophil migration by endogenous interleukin-8. Science 254:99-102, 1991
46. Wiley JS, Jamieson GP, Cebon JS, et al: Cytokine priming of acute myeloid leukemia may produce a pulmonary syndrome when associated with a rapid increase in peripheral blood myeloblasts. Blood 82:3511-3512, 1993
47. Suter PM, Suter S, Giardin E, et al: High bronchoalveolar levels of tumor necrosis factor and its inhibitors, interleukin-1, interferon, and elastase, in patients with adult respiratory distress syndrome after trauma, shock or sepsis. Am Rev Respir Dis 145:1016-1022, 1992
48. Donnelly SC, Streiter RM, Kunkel SL, et al: Interleukin-8 and development of adult respiratory distress syndrome in at-risk patient groups. Lancet 341:643-647, 1993